Androstenedione is the preferred androgen source in hormone refractory prostate cancer--letter.

Subjects

Subjects :

Androgen Antagonists therapeutic use
Humans
Male
Prostatic Neoplasms drug therapy
Androgens metabolism
Androstenedione metabolism
Drug Resistance, Neoplasm physiology
Prostatic Neoplasms metabolism

Details

Language :

English

ISSN :

1557-3265

Volume :

20

Issue :

18

Database :

MEDLINE

Journal :

Clinical cancer research : an official journal of the American Association for Cancer Research

Publication Type :

Editorial & Opinion

Accession number :

25225065

Full Text :

https://doi.org/10.1158/1078-0432.CCR-14-1123